NTAP
67
-3
AN
58
4
HD
57
2
NVDA
56
-4
HAS
33
3
XRAY
28
2
COF
60
2
CSCO
67
4
CA
38
6
WDC
47
4
PFG
45
3
STI
14
-17
ACN
52
3
SEE
56
6
APD
59
2
AMG
54
2
MAT
46
12
EFX
38
2
FE
50
-2
HPQ
63
6
NTAP
67
-3
AN
58
4
HD
57
2
NVDA
56
-4
HAS
33
3
XRAY
28
2
COF
60
2
CSCO
67
4
CA
38
6
WDC
47
4
PFG
45
3
STI
14
-17
ACN
52
3
SEE
56
6
APD
59
2
AMG
54
2
MAT
46
12
EFX
38
2
FE
50
-2
HPQ
63
6
Financhill
Back

Cytokinetics Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41

CYTK
Cytokinetics

Last Price:
49.09
Seasonality Move:
14.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Cytokinetics Stock Forecast

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 13.8% based on the past 20 years of stock performance.
  • Cytokinetics has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%
  • Is Cytokinetics Stock Undervalued?
    The current Cytokinetics [CYTK] share price is $49.10. The Score for CYTK is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Cytokinetics Stock Go Up Next Year?

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 13.8% based on the past 20 years of stock performance.

Cytokinetics Stock Rating

Sell
41
Cytokinetics (CYTK) is a Sell

Is Cytokinetics overpriced?

  • Cytokinetics has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%

Cytokinetics Stock Price History

Is CYTK stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com

52-Week Data

52-Week High:
110.25
52-Week Low:
30.68

Prediction Charts

Market Cap:
5.79B
Price in USD:
49.10
Volume:
1.48M
Beta:
1.44

Technical Analysis

SMA50:
53.63
SMA100:
54.90
SMA200:
59.51
52-Wk Change:
53.87%

Stock Predictions

  • Is Cytokinetics stock public?
    Yes, Cytokinetics is a publicly traded company.
  • What is the Cytokinetics stock quote today?
    The Cytokinetics stock price is 49.10 USD today.
  • How to buy Cytokinetics stock online?
    You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 51.31 52.52 53.00 50.88
Nov-6 53.99 55.50 55.68 53.19
Nov-7 54.99 55.84 57.48 54.63
Nov-8 56.31 57.98 58.74 56.10
Nov-11 59.31 58.62 59.39 57.80
Nov-12 58.33 56.21 58.95 56.08
Nov-13 56.79 55.95 57.75 55.95
Nov-14 55.74 54.70 56.31 54.56
Nov-15 55.14 50.22 55.14 49.86
Nov-18 50.24 51.94 52.01 49.64
Nov-19 51.66 51.09 51.80 49.67
Nov-20 50.77 49.86 50.95 49.65
Nov-21 50.33 47.67 50.45 47.56
Nov-22 47.67 49.10 49.82 47.41

Cytokinetics Earnings

Cytokinetics Earnings Report: Per Share Cytokinetics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cytokinetics Forecast Revenue Growth

Cytokinetics Stock Analysis: Historical quarterly revenues per share for Cytokinetics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.35 per share, and an increase next year of $0.07 per share.

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.